GlassScriptPhysician profile
Michael Brennan
NPI 1629436407
$7,574.93
in general payments reported to CMS, 2019-2025
39 companies · $1,014 in 2025
The $1,014 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,460 · 2022: $1,900 · 2023: $1,645 · 2024: $1,556 · 2025: $1,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,215.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,454.26 | 2021-2025 | |
| Boston Scientific Corporation | $1,141.19 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $716.09 | 2021-2025 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $454.98 | 2021-2024 | Relistor |
| Pfizer INC. | $442.74 | 2023-2025 | |
| Nalu Medical, INC. | $420.68 | 2022-2025 | Nalu Neurostimulation System |
| Abbott Laboratories | $381.41 | 2022-2025 | Proclaim |
| Biohaven Pharmaceuticals, INC. | $234.77 | 2021 | |
| Tersera Therapeutics LLC | $199.50 | 2023-2025 | Prialt |
| Biohaven Pharmaceutical Holding Company LTD. | $189.87 | 2022 | |
| Scilex Pharmaceuticals INC. | $169.91 | 2021-2023 | Ztlido |
| Amgen INC. | $168.92 | 2021-2023 | Aimovig |
| Relievant Medsystems, INC. | $159.74 | 2021-2022 | |
| Lundbeck LLC | $142.74 | 2022-2025 | Vyepti |
| Nevro Corp. | $115.98 | 2021-2023 | Senza |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $110.97 | 2025 | |
| Medtronic, INC. | $109.27 | 2021-2025 | Synchromedii, Intellis Adaptivestim |
| Ibsa Pharma INC. | $99.15 | 2021-2024 | Tirosint, Tirosint, Licart |
| Lilly USA, LLC | $91.74 | 2021-2023 | Reyvow, Emgality |
| Averitas Pharma INC. | $83.98 | 2023-2025 | Qutenza |
| Grt US Holding, INC. | $65.54 | 2022 | |
| Spr Therapeutics, INC | $64.51 | 2021-2024 | Sprint Pns System |
| Uswm, LLC | $62.36 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $53.33 | 2021-2025 | Rexulti |
| Saluda Medical Americas, INC. | $48.46 | 2023 | Evoke Scs |
| Redhill Biopharma INC. | $48.13 | 2021-2022 | |
| Spinal Simplicity, LLC | $44.80 | 2024-2025 | Ha Minuteman G3-R |
| Virtus Pharmaceuticals LLC | $38.52 | 2021 | |
| Valinor Pharma, LLC | $37.63 | 2025 | Movantik |
| Fidia Pharma USA INC. | $36.68 | 2022 | |
| Biodelivery Sciences International, INC. | $28.27 | 2021 | |
| Axsome Therapeutics, INC. | $28.06 | 2025 | Symbravo |
| Pacira Pharmaceuticals Incorporated | $24.48 | 2024 | Iovera, Zilretta |
| Painteq LLC | $20.67 | 2024 | Painteq |
| Almatica Pharma LLC | $19.74 | 2021 | |
| Allergan, INC. | $18.24 | 2021 | |
| Bioventus LLC | $17.89 | 2022 | |
| Tonix Medicines, INC. | $16.41 | 2025 | Tonmya |
| Horizon Therapeutics Plc | $13.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brennan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.